Amrize nine-month operating cash flow falls to $222M
Nine-month cash outflows included $750 million of common-stock repurchases and $364 million of dividends paid.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Amrize Ltd (AMRZ) reported third-quarter 2026 revenue of $3.771 billion, compared with $3.690 billion in the prior-year quarter, and net income attributable to the company of $559 million versus $542 million. For the nine months ended September 30, revenue was $9.445 billion versus $8.997 billion, and net income attributable to the company was $932 million versus $865 million. Operating cash flow for the nine months was $222 million, compared with $417 million.
Amrize completed its $425 million cash acquisition of PB Materials on February 18, 2026, and also completed the acquisition of Rapid Redi-Mix, a ready-mix concrete business in the Dallas-Fort Worth region. It repurchased $750 million of common stock and paid $364 million in dividends during the nine months. As of September 30, 2026, cash and cash equivalents were $299 million and $904 million was outstanding under its commercial paper program, at a 4.21% weighted-average interest rate. Amrize revised prior-period statements for an extended-warranty misstatement and other adjustments it described as immaterial to prior periods; it said corrections in the current period would have been material to the nine-month 2026 statements and forecasted 2026 results.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointNine-month net income attributable to Amrize was $932 million, versus $865 million.
Negative
- Moderate pointNine-month operating cash flow declined to $222 million from $417 million.
Key Figures
Key Terms
Segment Adjusted EBITDA financial
Commercial Paper Program financial
remaining performance obligations financial
cash flow hedges financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much of AMRZ's share repurchase authorization remained at September 30, 2026?
What dividends did Amrize pay per share in 2026?
AI-generated analysis. How Rhea-AI works. Not financial advice.


QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) |
6300 | |||||
(Address of Principal Executive Offices) | (Zip Code) | ||||
Title of each class | Trading symbol(s) | Name of exchange on which registered |
☒ | Accelerated filer | ☐ | ||
Non-accelerated filer | ☐ | Smaller reporting company | ||
Emerging growth company |


ITEM | PAGE |
PART I - FINANCIAL INFORMATION | 4 |
Item 1. Financial Statements | 4 |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 41 |
Item 3. Quantitative and Qualitative Disclosures About Market Risk | 55 |
Item 4. Controls and Procedures | 56 |
PART II - OTHER INFORMATION | 57 |
Item 1. Legal Proceedings | 57 |
Item 1A. Risk Factors | 57 |
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities | 58 |
Item 3. Defaults Upon Senior Securities | 58 |
Item 4. Mine Safety Disclosures | 58 |
Item 5. Other Information | 58 |
Item 6. Exhibits | 59 |
For the three months | For the nine months | |||||||
ended September 30, | ended September 30, | |||||||
2026 | 2025 | 2026 | 2025 | |||||
Revenues | $ | $ | $ | $ | ||||
Cost of revenues | ( | ( | ( | ( | ||||
Gross profit | ||||||||
Selling, general and administrative expenses | ( | ( | ( | ( | ||||
Gain on disposal of long-lived assets | ||||||||
Loss on impairments | ( | ( | ||||||
Operating income | ||||||||
Interest expense, net | ( | ( | ( | ( | ||||
Other non-operating income, net | ||||||||
Income before income tax expense and income from equity method investments | ||||||||
Income tax expense | ( | ( | ( | ( | ||||
Income from equity method investments | ||||||||
Net income | ||||||||
Net loss attributable to noncontrolling interests | ||||||||
Net income attributable to the Company | $ | $ | $ | $ | ||||
Earnings per share attributable to the Company: | ||||||||
Basic | $ | $ | $ | $ | ||||
Diluted | $ | $ | $ | $ | ||||
Weighted-average number of shares outstanding: | ||||||||
Basic | ||||||||
Diluted | ||||||||
For the three months | For the nine months | |||||||
ended September 30, | ended September 30, | |||||||
2026 | 2025 | 2026 | 2025 | |||||
Comprehensive income: | ||||||||
Net income | $ | $ | $ | $ | ||||
Other comprehensive income (loss), net of tax: | ||||||||
Foreign currency translation | ( | ( | ( | |||||
Net change in fair value of cash flow hedges, net of tax | ||||||||
Actuarial losses and prior service costs for defined benefit pension plans and other postretirement benefit plans, net of tax | ( | ( | ( | |||||
Total other comprehensive income (loss), net of tax | ( | ( | ( | |||||
Total comprehensive income | ||||||||
Comprehensive loss attributable to noncontrolling interests | ||||||||
Comprehensive income attributable to the Company | $ | $ | $ | $ | ||||
As of September 30, | As of December 31, | |||
2026 | 2025 | |||
(unaudited) | ||||
Assets | ||||
Current Assets: | ||||
Cash and cash equivalents | $ | $ | ||
Accounts receivable, net | ||||
Inventories, net | ||||
Prepaid expenses and other current assets | ||||
Total current assets | ||||
Property, plant and equipment, net | ||||
Goodwill | ||||
Intangible assets, net | ||||
Operating lease right-of-use assets, net | ||||
Other noncurrent assets | ||||
Total Assets | $ | $ | ||
Liabilities and Equity | ||||
Current Liabilities: | ||||
Accounts payable | $ | $ | ||
Short-term borrowings | ||||
Current portion of long-term debt | ||||
Operating lease liabilities | ||||
Other current liabilities | ||||
Total current liabilities | ||||
Long-term debt | ||||
Deferred income tax liabilities | ||||
Noncurrent operating lease liabilities | ||||
Other noncurrent liabilities | ||||
Total Liabilities | ||||
Commitments and contingencies (see Note 18) | ||||
Equity | ||||
Common stock, par value of $ | ||||
Additional paid-in capital | ||||
Retained earnings | ||||
Treasury stock, shares as of December 31, 2025 | ( | |||
Accumulated other comprehensive loss | ( | ( | ||
Total equity attributable to the Company | ||||
Noncontrolling interests | ( | ( | ||
Total Equity | ||||
Total Liabilities and Equity | $ | $ |
For the nine months ended September 30, | ||||
2026 | 2025 | |||
Cash Flows from Operating Activities: | ||||
Net income | $ | $ | ||
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||||
Depreciation, depletion, accretion and amortization | ||||
Share-based compensation | ||||
Deferred tax expense (benefit) | ( | |||
Other items, net | ||||
Changes in operating assets and liabilities, net of effects of acquisitions: | ||||
Accounts receivable, net | ( | ( | ||
Due from related party | ||||
Inventories, net | ( | ( | ||
Accounts payable | ( | |||
Due to related party | ( | |||
Other assets | ( | ( | ||
Other liabilities | ( | ( | ||
Defined benefit pension plans and other postretirement benefit plans | ( | ( | ||
Net cash provided by operating activities | ||||
Cash Flows from Investing Activities: | ||||
Purchases of property, plant and equipment | ( | ( | ||
Acquisitions, net of cash acquired | ( | ( | ||
Net decrease in short-term related-party notes receivable from cash pooling program | ||||
Other investing activities, net | ( | |||
Net cash used in investing activities | ( | ( | ||
Cash Flows from Financing Activities: | ||||
Transfers to Holcim, net | ( | |||
Proceeds from short-term borrowings, net | ||||
Proceeds from issuance of long-term debt, net of discount | ||||
Payments of debt issuance costs | ( | |||
Net repayments of short-term related-party debt | ( | |||
Proceeds from debt-for-debt exchange with Holcim | ||||
Proceeds from issuances of long-term related-party debt | ||||
Repayments of long-term related-party debt | ( | |||
Repayments of long-term third-party debt | ( | |||
Payments of finance lease obligations | ( | ( | ||
Repurchases of common stock | ( | |||
Dividends paid | ( | |||
Other financing activities, net | ( | |||
Net cash used in financing activities | ( | ( | ||
Effect of exchange rate changes on cash and cash equivalents | ( | |||
Decrease in cash and cash equivalents | ( | ( | ||
Cash and cash equivalents at the beginning of period | ||||
Cash and cash equivalents at the end of period | $ | $ | ||
Common stock | Treasury stock | Additional paid-in | Retained | Net parent | Accumulated other comprehensive | Equity attributable to noncontrolling | Total | |||
Shares | Amount | Shares | Amount | capital | earnings | investment | loss | interests | equity | |
Balance as of June 30, 2026 | $ | ( | $( | $ | $ | $ | $( | $( | $ | |
Net income (loss) | — | — | — | — | — | — | — | ( | ||
Other comprehensive loss, net of taxes | — | — | — | — | — | — | — | ( | — | ( |
Repurchases of common stock | — | — | ( | ( | — | — | — | — | — | ( |
Dividends | — | — | — | — | — | ( | — | — | — | ( |
Share-based compensation expense | — | — | — | — | — | — | — | — | ||
Shares withheld for employees’ income tax obligations and other | — | — | — | — | — | ( | — | — | — | ( |
Shares issued under employee share plans | — | — | — | — | — | — | — | — | ||
Balance as of September 30, 2026 | $ | ( | $( | $ | $ | $ | $( | $( | $ | |
Common stock | Treasury stock | Additional paid-in | Retained | Net parent | Accumulated other comprehensive | Equity attributable to noncontrolling | Total | |||
Shares | Amount | Shares | Amount | capital | earnings | investment | loss | interests | equity | |
Balance as of June 30, 2025 | $ | ( | $ | $ | $ | $ | $( | $( | $ | |
Net income (loss) | — | — | — | — | — | — | — | ( | ||
Other comprehensive loss, net of taxes | — | — | — | — | — | — | — | ( | — | ( |
Share-based compensation expense and other | — | — | — | — | ( | — | — | — | ||
Balance as of September 30, 2025 | $ | ( | $ | $ | $ | $ | $( | $( | $ | |
Common stock | Treasury stock | Additional paid-in | Retained | Net parent | Accumulated other comprehensive | Equity attributable to noncontrolling | Total | |||
Shares | Amount | Shares | Amount | capital | earnings | investment | loss | interests | equity | |
Balance as of December 31, 2025 | $ | ( | $ | $ | $ | $ | $( | $( | $ | |
Net income (loss) | — | — | — | — | — | — | — | ( | ||
Other comprehensive loss, net of taxes | — | — | — | — | — | — | — | ( | — | ( |
Repurchases of common stock | — | — | ( | ( | — | — | — | — | — | ( |
Dividends | — | — | — | — | — | ( | — | — | — | ( |
Share-based compensation expense | — | — | — | — | — | — | — | |||
Shares withheld for employees’ income tax obligations and other | — | — | — | — | ( | ( | — | — | — | ( |
Shares issued under employee share plans | — | — | — | — | — | — | — | — | ||
Balance as of September 30, 2026 | $ | ( | $( | $ | $ | $ | $( | $( | $ | |
Common stock | Treasury stock | Additional paid-in | Retained | Net parent | Accumulated other comprehensive | Equity attributable to noncontrolling | Total | |||
Shares | Amount | Shares | Amount | capital | earnings | investment | loss | interests | equity | |
Balance as of December 31, 2024 | $ | $ | $ | $ | $ | $( | $( | $ | ||
Net income (loss) | — | — | — | — | — | — | ( | |||
Other comprehensive income, net of taxes | — | — | — | — | — | — | — | — | ||
Changes in equity attributable to noncontrolling interests | — | — | — | — | — | — | ( | — | ||
Net transfers from Holcim including Spin- off-related adjustments | — | — | — | — | — | — | — | |||
Issuance of Common stock, Treasury stock and reclassification of Net parent investment | ( | — | — | ( | — | — | ||||
Share-based compensation expense and other | — | — | — | — | ( | — | — | — | ||
Balance as of September 30, 2025 | $ | ( | $ | $ | $ | $ | $( | $( | $ | |
Note Listing | Page |
Note 1. Organization and basis of presentation | 11 |
Note 2. New accounting standards | 13 |
Note 3. Revenues | 14 |
Note 4. Acquisitions | 14 |
Note 5. Accounts receivable, net | 15 |
Note 6. Inventories, net | 15 |
Note 7. Property, plant and equipment, net | 16 |
Note 8. Goodwill and intangible assets, net | 16 |
Note 9. Additional financial information | 17 |
Note 10. Debt | 18 |
Note 11. Leases | 19 |
Note 12. Asset retirement obligations | 20 |
Note 13. Income taxes | 21 |
Note 14. Segment information | 21 |
Note 15. Pension and other postretirement benefits | 24 |
Note 16. Derivatives | 25 |
Note 17. Accumulated other comprehensive loss | 26 |
Note 18. Commitments and contingencies | 27 |
Note 19. Related party | 29 |
Note 20. Supplemental cash flow information | 31 |
Note 21. Earnings per share and shareholders’ equity | 31 |
Note 22. Share-based compensation | 33 |
Note 23. Revision of prior period financial statements | 33 |
Note 24. Subsequent events | 40 |
For the three months | For the nine months | |||||||
ended September 30, | ended September 30, | |||||||
(In millions) | 2026 | 2025 | 2026 | 2025 | ||||
Building Materials | ||||||||
Cement | $ | $ | $ | $ | ||||
Aggregates and other construction materials | ||||||||
Interproduct revenues | ( | ( | ( | ( | ||||
Building Envelope | ||||||||
Total Revenues | $ | $ | $ | $ | ||||
(In millions) | Total 2026 Acquisitions | |
Total assets and liabilities acquired | ||
Inventories | ||
Property, plant and equipment | ||
Intangible assets | ||
Other, primarily right-of-use assets | ||
Deferred tax liabilities | ( | |
Other liabilities assumed | ( | |
Total identifiable net assets at fair value | ||
Goodwill | ||
Total estimated fair value of net assets | $ | |
Total consideration | $ | |
Less: Deferred consideration | ||
Cash consideration | $ |
As of | As of | |||
(In millions) | September 30, 2026 | December 31, 2025 | ||
Trade receivables | $ | $ | ||
Less: allowance for credit losses | ( | ( | ||
Other current receivables, net | ||||
Accounts receivable, net | $ | $ |
(In millions) | 2026 | 2025 | ||
Balance as of January 1 | $ | $ | ||
Charge-offs | ( | |||
Provision for credit losses | ||||
Foreign currency translation and other | ( | |||
Balance as of September 30 | $ | $ |
As of | As of | |||
(In millions) | September 30, 2026 | December 31, 2025 | ||
Raw materials, parts, and supplies | $ | $ | ||
Semi-finished and finished goods | ||||
Total inventories, net | $ | $ |
As of | As of | |||
(In millions) | September 30, 2026 | December 31, 2025 | ||
Land and mineral reserves | $ | $ | ||
Buildings and installations | ||||
Machines, furniture, vehicles and tools | ||||
Construction in progress | ||||
Finance lease right-of-use assets | ||||
Total property, plant and equipment | ||||
Less: accumulated depreciation, depletion and impairment | ( | ( | ||
Property, plant and equipment, net | $ | $ |
(In millions) | Building Materials | Building Envelope | Total | |||
Balance as of January 1, 2026 | $ | $ | $ | |||
Acquisitions | ||||||
Foreign currency translation adjustment and other | ( | ( | ||||
Balance as of September 30, 2026 | $ | $ | $ |
As of | As of | |||
(In millions) | September 30, 2026 | December 31, 2025 | ||
Employee-related liabilities other than pension | $ | $ | ||
Finance lease liabilities | ||||
Accrued purchases of property, plant and equipment | ||||
Accrued interest | ||||
Income tax payable | ||||
Contract liabilities | ||||
Indirect taxes | ||||
Asset retirement obligations | ||||
Self-insurance reserves | ||||
Pension liabilities | ||||
Standard warranty reserves | ||||
Other | ||||
Total Other current liabilities | $ | $ |
As of | As of | |||
(In millions) | September 30, 2026 | December 31, 2025 | ||
Contract liabilities | $ | $ | ||
Finance lease liabilities | ||||
Asset retirement obligations | ||||
Pension liabilities | ||||
Liabilities for unrecognized tax benefits | ||||
Self-insurance reserves | ||||
Standard warranty reserves | ||||
Environmental remediation liabilities | ||||
Other | ||||
Total Other noncurrent liabilities | $ | $ |
Effective interest rate as of September 30, | As of September 30, | As of December 31, | ||||
(In millions) | 2026 | 2026 | 2025 | |||
$ | $ | |||||
Other | ||||||
Total principal | ||||||
Unamortized premiums and debt issuance costs | ||||||
Total long-term debt | ||||||
Less: current portion of long-term debt | ( | ( | ||||
Long-term debt | $ | $ |
(In millions) | As of September 30, 2026 | |
Carrying amount | $ | |
Fair value | $ |
As of | As of | |||
(In millions) | September 30, 2026 | December 31, 2025 | ||
Operating lease right-of-use assets, net | $ | $ | ||
Finance lease right-of-use assets, net | ||||
Total lease assets, net | $ | $ | ||
Current portion of operating lease liabilities | $ | $ | ||
Current portion of finance lease liabilities | ||||
Noncurrent portion of operating lease liabilities | ||||
Noncurrent portion of finance lease liabilities | ||||
Total lease liabilities | $ | $ |
For the three months | For the nine months | |||||||
ended September 30, | ended September 30, | |||||||
(In millions) | 2026 | 2025 | 2026 | 2025 | ||||
Operating lease expense | $ | $ | $ | $ | ||||
Finance lease expense: | ||||||||
Amortization of leased assets | ||||||||
Interest on lease liabilities | ||||||||
Short term lease cost | ||||||||
Variable lease cost | ||||||||
Total lease expense | $ | $ | $ | $ | ||||
For the three months | For the nine months | |||||||
ended September 30, | ended September 30, | |||||||
(In millions) | 2026 | 2025 | 2026 | 2025 | ||||
Accretion | $ | $ | $ | $ | ||||
Depreciation | ||||||||
Total costs | $ | $ | $ | $ | ||||
As of | As of | |||
(In millions) | September 30, 2026 | December 31, 2025 | ||
Current ARO liability | $ | $ | ||
Noncurrent ARO liability | ||||
Total ARO liability | $ | $ |
(In millions) | 2026 | |
Balance as of January 1 | $ | |
Accretion expense | ||
Liabilities settled | ( | |
Foreign currency translation adjustment | ( | |
Balance as of September 30 | $ |
For the three months | For the nine months | |||||||
ended September 30, | ended September 30, | |||||||
(In millions, except for percentage data) | 2026 | 2025 | 2026 | 2025 | ||||
Total income tax expense | $ | $ | $ | $ | ||||
Effective income tax rate | ||||||||
For the three months | For the nine months | |||||||
ended September 30, | ended September 30, | |||||||
(In millions) | 2026 | 2025 | 2026 | 2025 | ||||
Revenues: | ||||||||
Building Materials | $ | $ | $ | $ | ||||
Building Envelope | ||||||||
Total Revenues | $ | $ | $ | $ | ||||
Cost of revenues: | ||||||||
Building Materials | $ | $ | $ | $ | ||||
Building Envelope | ||||||||
Total cost of revenues | $ | $ | $ | $ | ||||
Other segment expenses(1): | ||||||||
Building Materials | $ | $ | $ | $ | ||||
Building Envelope | ||||||||
Total other segment expenses | $ | $ | $ | $ | ||||
Segment Adjusted EBITDA: | ||||||||
Building Materials | $ | $ | $ | $ | ||||
Building Envelope | ||||||||
Total Segment Adjusted EBITDA | $ | $ | $ | $ | ||||
For the three months | For the nine months | |||||||
ended September 30, | ended September 30, | |||||||
(In millions) | 2026 | 2025 | 2026 | 2025 | ||||
Total Segment Adjusted EBITDA | $ | $ | $ | $ | ||||
Reconciling items: | ||||||||
Depreciation, depletion, accretion and amortization | ( | ( | ( | ( | ||||
Interest income | ||||||||
Interest expense | ( | ( | ( | ( | ||||
Acquisition and integration-related costs(1) | ( | ( | ( | |||||
Litigation-related settlements (costs)(2) | ( | ( | ( | |||||
Loss on impairments(3) | ( | ( | ||||||
Restructuring and other costs(4) | ( | ( | ( | ( | ||||
Spin-off and separation-related costs(5) | ( | ( | ( | ( | ||||
Unallocated corporate costs | ( | ( | ( | ( | ||||
Other non-operating income, net(6) | ||||||||
Total reconciling items | ( | ( | ( | ( | ||||
Income before income tax expense and income from equity method investments | $ | $ | $ | $ | ||||
For the three months | For the nine months | |||||||
ended September 30, | ended September 30, | |||||||
(In millions) | 2026 | 2025 | 2026 | 2025 | ||||
Capital expenditures(1): | ||||||||
Building Materials | $ | $ | $ | $ | ||||
Building Envelope | ||||||||
Total capital expenditures | $ | $ | $ | $ | ||||
As of | As of | |||
(In millions) | September 30, 2026 | December 31, 2025 | ||
Segment assets(1): | ||||
Building Materials | $ | $ | ||
Building Envelope | ||||
Total segment assets | ||||
Other assets(2) | ||||
Total assets | $ | $ |
Balance | As of | As of | ||||
(in millions) | Sheet Location | September 30, 2026 | December 31, 2025 | |||
Assets: | ||||||
Commodity swaps | Prepaid expenses and other current assets | $ | $ | |||
Commodity swaps | Other noncurrent assets | |||||
Liabilities: | ||||||
Commodity swaps | Other current liabilities | |||||
Commodity swaps | Other noncurrent liabilities | |||||
Foreign currency contracts | Other noncurrent liabilities |
Location of Gain (Loss) | For the three months ended | |||||
(in millions) | Recognized in Income | September 30, 2026 | September 30, 2025 | |||
Commodity swaps — Recognized in OCI | OCI (pretax) | $( | $ | |||
Commodity swaps — Reclassified from OCI | Cost of revenues | ( | ||||
Foreign currency contracts | Interest expense, net | ( | ||||
Location of Gain (Loss) | For the nine months ended | |||||
(in millions) | Recognized in Income | September 30, 2026 | September 30, 2025 | |||
Commodity swaps — Recognized in OCI | OCI (pretax) | $( | $ | |||
Commodity swaps — Reclassified from OCI | Cost of revenues | ( | ||||
Foreign currency contracts | Interest expense, net | ( | ||||
(In millions) | Foreign Currency Translation Adjustment | Cash Flow Hedges | Defined Benefit Pension Plans and Other Postretirement Benefit Plans | Total | ||||
Balance as of June 30, 2026 | $( | $ | $ | $( | ||||
Other comprehensive income (loss) before reclassifications | ( | ( | ( | ( | ||||
Amounts reclassified from Accumulated other comprehensive loss to Net income | ||||||||
Net current-period Other comprehensive income (loss) | ( | ( | ( | |||||
Balance as of September 30, 2026 | $( | $ | $ | $( | ||||
Balance as of June 30, 2025 | $( | $ | $ | $( | ||||
Other comprehensive income (loss) before reclassifications | ( | ( | ||||||
Amounts reclassified from Accumulated other comprehensive loss to Net income | ( | ( | ||||||
Net current-period Other comprehensive income (loss) | ( | ( | ||||||
Balance as of September 30, 2025 | $( | $ | $ | $( |
(In millions) | Foreign Currency Translation Adjustment | Cash Flow Hedges | Defined Benefit Pension Plans and Other Postretirement Benefit Plans | Total | ||||
Balance as of December 31, 2025 | $( | $( | $ | $( | ||||
Other comprehensive income (loss) before reclassifications | ( | ( | ( | ( | ||||
Amounts reclassified from Accumulated other comprehensive loss to Net income | ( | |||||||
Net current-period Other comprehensive income (loss) | ( | ( | ( | |||||
Balance as of September 30, 2026 | $( | $ | $ | $( | ||||
Balance as of December 31, 2024 | $( | $( | $ | $( | ||||
Other comprehensive (loss) income before reclassifications | ||||||||
Amounts reclassified from Accumulated other comprehensive loss to Net income | ( | ( | ( | |||||
Net current-period Other comprehensive (loss) income | ( | |||||||
Unrecognized gain transferred from Holcim pension | ||||||||
Balance as of September 30, 2025 | $( | $ | $ | $( |
For the three months | For the nine months | ||||||
ended September 30, | ended September 30, | ||||||
(In millions) | 2026 | 2025 | 2026 | 2025 | |||
Net change in fair value of effective portion of cash flow hedges | |||||||
Cost of revenues | $ | $( | $ | $( | |||
Income tax benefit (expense) | ( | ( | |||||
Total | $ | $( | $ | $( | |||
Actuarial losses and prior service costs for defined benefit pension plans and other postretirement benefit plans | |||||||
Other non-operating income, net | $ | $( | $( | $( | |||
Income tax benefit (expense) | |||||||
Total | $ | $ | $( | $( | |||
Total amounts reclassified from Accumulated other comprehensive loss to Net income | $ | $( | $ | $( | |||
(In millions) | 2026 | 2025 | ||
Balance as of January 1 | $ | $ | ||
Increase for warranties | ||||
Decrease for payments | ( | ( | ||
Balance as of September 30 | $ | $ |
For the nine months ended September 30, | ||||
(In millions) | 2026 | 2025 | ||
Interest paid, net | $ | $ | ||
Income taxes paid, net | ||||
Operating cash flows used for operating leases | ( | ( | ||
Operating cash flows used for finance leases | ( | ( | ||
Financing cash flows used for finance leases | ( | ( | ||
For the nine months ended September 30, | ||||
(In millions) | 2026 | 2025 | ||
Accrued purchases of property, plant and equipment | $ | $ | ||
Right-of-use assets obtained in exchange for new operating lease liabilities | ||||
Right-of-use assets obtained in exchange for new finance lease liabilities | ||||
Equity contribution from Holcim related to the settlement of Related- party notes payable | ||||
Debt assumed in connection with a business combination | ||||
For the three months | For the nine months | |||||||
ended September 30, | ended September 30, | |||||||
(In millions, except per share data) | 2026 | 2025 | 2026 | 2025 | ||||
Numerator: | ||||||||
Net income | $ | $ | $ | $ | ||||
Net loss attributable to noncontrolling interests | ||||||||
Net income attributable to the Company | $ | $ | $ | $ | ||||
Denominator: | ||||||||
Basic weighted-average number of shares outstanding | ||||||||
Dilutive effect of share-based awards | ||||||||
Diluted weighted-average number of shares outstanding | ||||||||
Earnings per share | ||||||||
Basic | $ | $ | $ | $ | ||||
Diluted | $ | $ | $ | $ | ||||
For the three months ended September 30, 2025 | For the nine months ended September 30, 2025 | |||||||
(in millions) | As reported | Adj | As revised | As reported | Adj | As revised | ||
Revenues | $ | $ | $ | $ | $ | $ | ||
Cost of revenues | ( | ( | ( | ( | ( | ( | ||
Gross profit | ( | |||||||
Selling, general and administrative expenses | ( | ( | ( | ( | ( | |||
Gain on disposal of long-lived assets | ||||||||
Loss on impairments | ( | ( | ||||||
Operating income | ||||||||
Interest expense, net | ( | ( | ( | ( | ||||
Other non-operating income, net | ||||||||
Income before income tax expense | ||||||||
Income tax expense | ( | ( | ( | ( | ( | ( | ||
Income from equity method investments | ||||||||
Net income | ( | ( | ||||||
Net loss attributable to noncontrolling interests | ||||||||
Net income attributable to the Company | $ | $( | $ | $ | $( | $ | ||
Earnings per share attributable to the Company: | ||||||||
Basic | $ | $( | $ | $ | $( | $ | ||
Diluted | $ | $ | $ | $ | $( | $ | ||
Weighted-average number of shares outstanding: | ||||||||
Basic | ||||||||
Diluted | ||||||||
For the three months ended September 30, 2025 | For the nine months ended September 30, 2025 | |||||||
(in millions) | As reported | Adj | As revised | As reported | Adj | As revised | ||
Net income | $ | $( | $ | $ | $( | $ | ||
Other comprehensive income (loss), net of tax: | ||||||||
Foreign currency translation | ( | ( | ||||||
Net change in fair value of effective portion of cash flow hedges, net of tax | ||||||||
Actuarial (losses) gains and prior service (costs) credits for pension and other postretirement plans, net of tax | ( | ( | ||||||
Total other comprehensive income (loss), net of tax | ( | ( | ||||||
Total comprehensive income | ( | ( | ||||||
Comprehensive loss attributable to noncontrolling interests | ||||||||
Comprehensive income attributable to the Company | $ | $( | $ | $ | $( | $ | ||
As of December 31, | ||||
2025 | ||||
(in millions) | As reported | Adj | As revised | |
Assets | ||||
Current Assets: | ||||
Cash and cash equivalents | $ | $ | $ | |
Accounts receivable, net | ( | |||
Inventories, net | ( | |||
Prepaid expenses and other current assets | ||||
Total current assets | ( | |||
Property, plant and equipment, net | ||||
Goodwill | ||||
Intangible assets, net | ||||
Operating lease right-of-use assets, net | ||||
Other noncurrent assets | ( | |||
Total Assets | $ | $( | $ | |
Liabilities and Equity | ||||
Current Liabilities: | ||||
Accounts payable | $ | $( | $ | |
Current portion of long-term debt | ||||
Operating lease liabilities | ||||
Other current liabilities | ||||
Total current liabilities | ||||
Long-term debt | ||||
Deferred income tax liabilities | ( | |||
Noncurrent operating lease liabilities | ||||
Other noncurrent liabilities | ||||
Total Liabilities | ||||
Commitments and contingencies (see Note 18) | ||||
Equity | ||||
Common stock, par value of $ December 31, 2025 | ||||
Additional paid-in capital | ( | |||
Retained earnings | ||||
Treasury stock, 2025 | ||||
Accumulated other comprehensive loss | ( | ( | ||
Total equity attributable to the Company | ( | |||
Noncontrolling interests | ( | ( | ||
Total Equity | ( | |||
Total Liabilities and Equity | $ | $( | $ | |
For the nine months ended September 30, 2025 | ||||
(in millions) | As reported | Adj | As revised | |
Cash Flows from Operating Activities: | ||||
Net income | $ | $( | $ | |
Adjustments to reconcile net income to net cash provided by operating activities: | ||||
Depreciation, depletion, accretion and amortization | ||||
Share-based compensation | ||||
Deferred tax expense | ||||
Other items, net | ( | |||
Changes in operating assets and liabilities, net of effects of acquisitions: | ||||
Accounts receivable, net | ( | ( | ||
Due from related-party | ||||
Inventories | ( | ( | ||
Accounts payable | ||||
Due to related-party | ( | ( | ( | |
Other assets | ( | ( | ( | |
Other liabilities | ( | ( | ||
Defined benefit pension plans and other postretirement benefit plans | ( | ( | ||
Net cash provided by operating activities | $ | $ | $ | |
Cash Flows from Investing Activities: | ||||
Purchases of property, plant and equipment | ( | ( | ( | |
Net cash used in investing activities | $( | $( | $( | |
Cash Flows from Financing Activities: | ||||
Transfers to Holcim, net | ( | ( | ( | |
Net cash used in financing activities | $( | $( | $( | |
Common | Additional | Retained | |||||||
stock | paid-in capital | earnings | |||||||
(in millions) | As reported | Adj | As revised | As reported | Adj | As revised | As reported | Adj | As revised |
Balance as of June 30, 2025 | $ | $ | $ | $ | $( | $ | $ | $ | $ |
Net income (loss) | — | — | — | — | — | — | ( | ||
Other comprehensive income, net of taxes | — | — | — | — | — | — | — | — | — |
Share-based compensation expense and other | — | — | — | — | ( | — | ( | ||
Balance as of September 30, 2025 | $ | $ | $ | $ | $( | $ | $ | $( | $ |
Accumulated other comprehensive | Equity attributable to | Total | |||||||
income | noncontrolling interest | equity | |||||||
(in millions) | As reported | Adj | As revised | As reported | Adj | As revised | As reported | Adj | As revised |
Balance as of June 30, 2025 | $( | $ | $( | $( | $ | $( | $ | $( | $ |
Net income (loss) | — | — | — | ( | — | ( | ( | ||
Other comprehensive income, net of taxes | ( | — | ( | — | — | — | ( | ( | |
Share-based compensation expense and other | — | — | — | — | — | — | |||
Balance as of September 30, 2025 | $( | $ | $( | $( | $ | $( | $ | $( | $ |
Common | Additional | Retained | Net parent | |||||||||
stock | paid-in capital | earnings | investment | |||||||||
(in millions) | As reported | Adj | As revised | As reported | Adj | As revised | As reported | Adj | As revised | As reported | Adj | As revised |
Balance as of December 31, 2024 | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $( | $ |
Net income (loss) | — | — | — | — | — | — | ( | ( | ||||
Other comprehensive income, net of taxes | — | — | — | — | — | — | — | — | — | — | — | — |
Changes in equity attributable to noncontrolling interests | — | — | — | — | — | — | — | — | — | ( | — | ( |
Net transfers from Holcim including Spin-off- related adjustments | — | — | — | — | — | — | — | — | — | ( | ||
Issuance of Common stock, Treasury stock and reclassification of Net parent investment | — | ( | — | — | — | ( | ( | |||||
Share-based compensation expense and other | — | — | — | — | ( | — | ( | — | — | — | ||
Balance as of September 30, 2025 | $ | $ | $ | $ | $( | $ | $ | $( | $ | $ | $ | $ |
Accumulated other comprehensive | Equity attributable to | Total | |||||||
income | noncontrolling interest | equity | |||||||
(in millions) | As reported | Adj | As revised | As reported | Adj | As revised | As reported | Adj | As revised |
Balance as of December 31, 2024 | $( | $ | $( | $( | $ | $( | $ | $( | $ |
Net income (loss) | — | — | — | ( | — | ( | ( | ||
Other comprehensive income, net of taxes | — | — | — | — | |||||
Changes in equity attributable to noncontrolling interests | — | — | — | — | |||||
Net transfers from Holcim including Spin-off- related adjustments | — | — | — | — | ( | ||||
Issuance of Common stock, Treasury stock and reclassification of Net parent investment | — | — | — | — | — | — | |||
Share-based compensation expense and other | — | — | — | — | — | — | |||
Balance as of September 30, 2025 | $( | $ | $( | $( | $ | $( | $ | $( | $ |
For the three months | For the nine months | ||||||
ended September 30, | ended September 30, | ||||||
(In millions, except for percentage data) | 2026 | 2025 | 2026 | 2025 | |||
Revenues | $3,771 | $3,690 | $9,445 | $8,997 | |||
Net income | $558 | $540 | $927 | $862 | |||
Net income margin | 14.8% | 14.6% | 9.8% | 9.6% | |||
Adjusted EBITDA(1) | $1,076 | $1,074 | $2,253 | $2,231 | |||
Adjusted EBITDA Margin(1) | 28.5% | 29.1% | 23.9% | 24.8% | |||
Cash flows provided by operating activities | $697 | $858 | $222 | $417 | |||
For the three months | For the nine months | ||||||||||
ended September 30, | ended September 30, | ||||||||||
(In millions, except for percentage data) | 2026 | 2025 | % Change | 2026 | 2025 | % Change | |||||
Revenues | $3,771 | $3,690 | 2.2% | $9,445 | $8,997 | 5.0% | |||||
Cost of revenues | (2,690) | (2,598) | (3.5)% | (7,163) | (6,727) | (6.5)% | |||||
Gross profit | 1,081 | 1,092 | (1.0)% | 2,282 | 2,270 | 0.5% | |||||
Selling, general and administrative expenses | (291) | (313) | 7.0% | (859) | (842) | (2.0)% | |||||
Gain on disposal of long-lived assets | 3 | 4 | (25.0)% | 11 | 9 | 22.2% | |||||
Loss on impairments | — | — | —% | (2) | (2) | —% | |||||
Operating income | 793 | 783 | 1.3% | 1,432 | 1,435 | (0.2)% | |||||
Interest expense, net | (89) | (89) | —% | (256) | (328) | 22.0% | |||||
Other non-operating income, net | 2 | — | n/m | 3 | 2 | 50.0% | |||||
Income before income tax expense and income from equity method investments | 706 | 694 | 1.7% | 1,179 | 1,109 | 6.3% | |||||
Income tax expense | (153) | (158) | 3.2% | (258) | (252) | (2.4)% | |||||
Income from equity method investments | 5 | 4 | 25.0% | 6 | 5 | 20.0% | |||||
Net income | 558 | 540 | 3.3% | 927 | 862 | 7.5% | |||||
Net loss attributable to noncontrolling interests | 1 | 2 | (50.0)% | 5 | 3 | 66.7% | |||||
Net income attributable to the Company | $559 | $542 | 3.1% | $932 | $865 | 7.7% | |||||
Net income margin | 14.8% | 14.6% | 9.8% | 9.6% | |||||||
Adjusted EBITDA(1) | $1,076 | $1,074 | 0.2% | $2,253 | $2,231 | 1.0% | |||||
Adjusted EBITDA Margin(1) | 28.5% | 29.1% | 23.9% | 24.8% | |||||||
Analysis of Change | ||||||||||||
(In millions, except for percentage data) | For the three months ended September 30, 2025 | Organic Growth | Acquisitions | Foreign Exchange | For the three months ended September 30, 2026 | % Change | ||||||
Total Revenues | $3,690 | $10 | $77 | $(6) | $3,771 | 2.2% | ||||||
Analysis of Change | ||||||||||||
(In millions, except for percentage data) | For the nine months ended September 30, 2025 | Organic Growth | Acquisitions | Foreign Exchange | For the nine months ended September 30, 2026 | % Change | ||||||
Total Revenues | $8,997 | $275 | $154 | $19 | $9,445 | 5.0% | ||||||
For the three months ended September 30, | For the nine months ended September 30, | |||||||||||
(In millions) | 2026 | 2025 | % Change | 2026 | 2025 | % Change | ||||||
Segment revenues: | ||||||||||||
Building Materials(1) | $2,842 | $2,793 | 1.8% | $6,789 | $6,393 | 6.2% | ||||||
Building Envelope | 929 | 897 | 3.6% | 2,656 | 2,604 | 2.0% | ||||||
Total revenues | $3,771 | $3,690 | 2.2% | $9,445 | $8,997 | 5.0% | ||||||
For the three months ended September 30, | For the nine months ended September 30, | |||||||||||
(In millions) | 2026 | 2025 | % Change | 2026 | 2025 | % Change | ||||||
Segment Adjusted EBITDA: | ||||||||||||
Building Materials | $938 | $913 | 2.7% | $1,898 | $1,799 | 5.5% | ||||||
Building Envelope | 182 | 213 | (14.6)% | 499 | 586 | (14.8)% | ||||||
Total Segment Adjusted EBITDA | 1,120 | 1,126 | (0.5)% | 2,397 | 2,385 | 0.5% | ||||||
Unallocated corporate costs | (44) | (52) | 15.4% | (144) | (154) | 6.5% | ||||||
Adjusted EBITDA(2) | $1,076 | $1,074 | 0.2% | $2,253 | $2,231 | 1.0% | ||||||
Volumes | For the three months ended September 30, | For the nine months ended September 30, | |||||
in millions | 2026 | 2025 | % Change | 2026 | 2025 | % Change | |
Cement - tons sold1 | 6.8 | 7.1 | (4.2%) | 17.3 | 16.7 | 3.6% | |
Aggregates - tons sold | 40.1 | 40.2 | (0.2%) | 92.3 | 88.0 | 4.9% | |
Average Selling Price - Year over Year | For the three months ended September 30, | |||||
$ per ton | 2026 | 2025 | % Change | Constant Currency2 | % Change Constant Currency | |
Cement - price per ton1 | $172.85 | $170.02 | 1.7% | $173.10 | 1.8% | |
Aggregates - price per ton3 | $14.76 | $13.85 | 6.6% | $14.80 | 6.9% | |
Average Selling Price - Year over Year | For the nine months ended September 30, | |||||
$ per ton | 2026 | 2025 | % Change | Constant Currency2 | % Change Constant Currency | |
Cement - price per ton1 | $171.36 | $170.82 | 0.3% | $171.09 | 0.2% | |
Aggregates - price per ton3 | $14.87 | $14.15 | 5.1% | $14.82 | 4.7% | |
Average Selling Price - Sequential | For the three months ended | |||||
Constant Currency2 | ||||||
$ per ton | September 30, 2026 | June 30, 2026 | % Change | September 30, 2026 | June 30, 2026 | % Change |
Cement - price per ton1 | $172.85 | $171.43 | 0.8% | $173.10 | $171.19 | 1.1% |
Aggregates - price per ton3 | $14.76 | $14.67 | 0.6% | $14.80 | $14.61 | 1.3% |
For the three months | For the nine months | |||||||
ended September 30, | ended September 30, | |||||||
(In millions, except for percentage data) | 2026 | 2025 | 2026 | 2025 | ||||
Net income | $558 | $540 | $927 | $862 | ||||
Depreciation, depletion, accretion and amortization | 263 | 239 | 757 | 683 | ||||
Interest expense, net | 89 | 89 | 256 | 328 | ||||
Income tax expense | 153 | 158 | 258 | 252 | ||||
EBITDA | 1,063 | 1,026 | 2,198 | 2,125 | ||||
Acquisition and integration-related costs(1) | 4 | (2) | 30 | 19 | ||||
Litigation-related (settlements) costs(2) | 1 | 40 | (2) | 44 | ||||
Loss on impairments(3) | — | — | 2 | 2 | ||||
Restructuring and other costs(4) | 7 | 4 | 16 | 13 | ||||
Spin-off and separation-related costs(5) | 8 | 10 | 18 | 35 | ||||
Other non-operating income, net(6) | (2) | — | (3) | (2) | ||||
Income from equity method investments | (5) | (4) | (6) | (5) | ||||
Adjusted EBITDA | 1,076 | 1,074 | 2,253 | 2,231 | ||||
Unallocated corporate costs | 44 | 52 | 144 | 154 | ||||
Total Segment Adjusted EBITDA | $1,120 | $1,126 | $2,397 | $2,385 | ||||
Building Materials | $938 | $913 | $1,898 | $1,799 | ||||
Building Envelope | $182 | $213 | $499 | $586 | ||||
Net income margin | 14.8% | 14.6% | 9.8% | 9.6% | ||||
EBITDA Margin | 28.2% | 27.8% | 23.3% | 23.6% | ||||
Adjusted EBITDA Margin | 28.5% | 29.1% | 23.9% | 24.8% | ||||
For the nine months ended September 30, | ||||
(In millions) | 2026 | 2025 | ||
Net cash provided by operating activities | $222 | $417 | ||
Capital expenditures, net: | ||||
Purchases of property, plant and equipment | (786) | (637) | ||
Proceeds from disposals of long-lived assets | 13 | 12 | ||
Proceeds from land expropriation | — | 20 | ||
Proceeds from property and casualty insurance | — | 2 | ||
Total capital expenditures, net(1) | (773) | (603) | ||
Free cash flow | $(551) | $(186) | ||
For the nine months ended September 30, | ||||
(In millions) | 2026 | 2025 | ||
Net cash provided by (used in): | ||||
Operating activities | $222 | $417 | ||
Investing activities | (1,202) | (217) | ||
Financing activities | (628) | (985) | ||
Effect of exchange rate changes on cash and cash equivalents | (15) | 26 | ||
Decrease in cash and cash equivalents | (1,623) | (759) | ||
Cash and cash equivalents - beginning of period | 1,922 | 1,585 | ||
Cash and cash equivalents - end of period | $299 | $826 | ||
(In millions) | Remainder of 2026 | 2027 | 2028 | 2029 | 2030 | Thereafter | Total | |||||||
Principal on debt and other borrowings | $912 | $700 | $700 | $3 | $1,000 | $2,529 | $5,844 | |||||||
Operating lease obligations | 45 | 167 | 133 | 106 | 75 | 290 | 816 | |||||||
Finance lease obligations | 36 | 131 | 103 | 71 | 45 | 130 | 516 | |||||||
Pension and postretirement contributions | 6 | 27 | 25 | 24 | 23 | 411 | 516 | |||||||
Purchase obligations(1) | 643 | 121 | 62 | 105 | 40 | 177 | 1,148 | |||||||
Total | $1,642 | $1,146 | $1,023 | $309 | $1,183 | $3,537 | $8,840 |
Period | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs1 | Maximum Number of Shares that May Yet Be Purchased Under the Plans or Program2 | ||||
July 1 - July 31 | 3,146,295 | 50.85 | 3,146,295 | 17,189,145 | ||||
August 1 - August 31 | 4,175,627 | 46.75 | 4,175,627 | 11,967,794 | ||||
September 1 - September 30 | 5,736,940 | 40.86 | 5,736,940 | 5,698,852 | ||||
Total | 13,058,862 | 13,058,862 |
Exhibit No. | Exhibit |
10.1 | Employment Agreement dated August 24, 2026, by and between Amrize Ltd and Samuel J. Poletti (Exhibit 10.1 to the Company’s Form 8-K filed August 24, 2026, File No. 1-42542, and incorporated herein by reference). |
10.2 | International Assignment Agreement dated August 24, 2026, by and among Amrize Ltd, Amrize North America Inc. and Samuel J. Poletti (Exhibit 10.2 to the Company’s Form 8-K filed August 24, 2026, File No. 1-42542, and incorporated herein by reference). |
10.3* | Employment Agreement dated September 11, 2026, by and between Amrize Technology Switzerland LLC and Mario Gross. |
10.4* | International Assignment Agreement dated September 11, 2026, by and among Amrize Technology Switzerland LLC, Amrize Building Envelope LLC, and Mario Gross. |
31.1* | Certification of CEO, Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
31.2* | Certification of CFO, Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
32** | Certification of CEO and CFO Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
95* | Disclosure of Mine Safety and Health Administration (MSHA) Safety Data. |
101* | Inline eXtensible Business Reporting Language (XBRL). |
104 | Cover Page Interactive Data File (formatted in iXBRL in Exhibit 101). |
Amrize Ltd | ||
By: | /s/ Samuel Poletti | |
Name: | Samuel Poletti | |
Title: | Chief Financial Officer (Duly authorized officer and principal financial officer) | |
Date: | October 29, 2026 | |